Baioflow uniquely integrates biology and AI through real experimental bio-data. This approach bridges the gap between laboratory research and computational models, enabling the discovery of organ-crossing enhancers (OCEs) and transforming predictions into practical drug delivery solutions.

An organ-crossing enhancer (OCE) is a molecular “key” that allows drugs to cross biological barriers — such as the blood–brain barrier (BBB) and other organ-specific barriers — that normally block therapeutic access. By enabling drugs to reach protected tissues like the brain, OCEs make precise, organ-targeted therapies possible and open new pathways for treating previously inaccessible diseases.

You can collaborate with Baioflow by reaching out through our Partnership Inquiry page. We welcome both biopharma companies and academic researchers who are exploring innovative drug delivery strategies for CNS and organ-specific therapies. Together, we can apply our organ-crossing enhancer (OCE) solutions to real programs and accelerate the development of next-generation therapeutics.